Skip to main content
57th ASAM Annual Conference Main banner
Final Program


Preview Program

Stephen M. Taylor, MD, MPH, DFAPA, DFASAM

Chief Medical Officer
Pathway Healthcare Services, LLC
Jonesboro, Georgia

Stephen M. Taylor, MD, MPH, DFAPA, DFASAM is the Chief Medical Officer of Pathway Healthcare, a company that operates 30 outpatient mental health and addiction treatment offices across Alabama, Mississippi, Tennessee, Iowa, and Southern California. Dr. Taylor is board-certified in psychiatry, child and adolescent psychiatry, addiction psychiatry, and addiction medicine, and has served as a practitioner, educator, and advocate for patients and families in all of these specialty and subspecialty areas for over 30 years. Dr. Taylor also served for 16-years as the Medical Director of the Player Assistance/Anti-Drug Program of the National Basketball Association (NBA) and the National Basketball Players Association (NBPA).
Dr. Taylor is a Distinguished Fellow of the American Psychiatric Association, and a Distinguished Fellow of the American Society of Addiction Medicine (DFASAM). He is the current President of ASAM, and in that capacity, chairs ASAM’s Board of Directors and Executive Council. He also chairs ASAM’s Delegation to the AMA House of Delegates.
Dr. Taylor is a certified Medical Review Officer (MRO) and serves on the Board of Directors of the Medical Review Officer Certification Council (MROCC). He also serves on the Scientific Advisory Board of the Foundation for Opioid Recovery Efforts and represents ASAM on the National Academy of Medicine's Opioid Collaborative.
An honors graduate of Harvard College, with a Bachelor's degree in History and Science, Dr. Taylor also holds a Master of Public Health degree from the Harvard T.S. Chan School of Public Health and a medical degree from Howard University College of Medicine. Dr. Taylor completed “Triple Board” residency training in pediatrics, psychiatry, and child and adolescent psychiatry at the Albert Einstein College of Medicine/Bronx Municipal Hospital Center, and then completed a fellowship in addiction psychiatry at NYU School of Medicine/Bellevue Hospital Center.

Disclosure information not submitted.

Presentation(s):